http://www.fpnotebook.com/
ProchlorperazineAka: Compazine
- Indications
- Nausea or Vomiting
- Migraine Headache
- Motion Sickness
- Vertigo
- Hiccups
- Mechanism
- Phenothiazine Antiemetic
- Dopamine 2 Antagonist
- Adverse effects
- Orthostatic Hypotension
- Extrapyramidal Reaction
- Reactions
- Akathisia (25-60% after single dose)
- Dystonic Reaction (4% after a single dose)
- Concurrent Benadryl 50 mg IV prevents Akathisia
- Vinson (2001) Ann Emerg Med 37(2):125
- Dosing
- Adults
- Compazine 5-10 mg PO/IV/IM q6-8 hours
- Compazine 25 mg PR q12 hours
- Sustained release Compazine 15 mg PO qam or 10 mg bid
- Children (over age 2 years or >10 kg)
- Compazine 0.1 mg/kg/dose PO/PR q6-8 hours
- Compazine 0.1 to 0.15 mg IM q6-8 hours
- Precautions
- IV dosing must be administered over 2 minutes or more
- Lowers Seizure threshold
- Efficacy
- Better Antiemetic than Phenergan in ER patients
- Ernst (2000) Ann Emerg Med 36(2):89
- References
- Johnson (1993) Harriet Lane, Mosby, p. 521
- (2002) Tarascon Pocket Pharmacopoeia, p. 67
- Olsen (2000) Am J Emerg Med 18(5):609
- Vinson (2001) Ann Emerg Med 37(2):125
Prochlorperazine (C0033229)
|
|---|
| Definition (MSH) | A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612) |
| Definition (CSP) | phenothiazine derivative used chiefly as an antiemetic. |
| Definition (NCI) | (pro-klor-PAIR-a-zeen) A drug that prevents or reduces nausea and vomiting. It belongs to the family of drugs called antiemetics. |
| Definition (PDQ) | A synthetic propylpiperazine derivative of phenothiazine with antiemetic, antipsychotic, antihistaminic, and anticholinergic activities. Prochlorperazine antagonizes the dopamine D2-receptor in the chemoreceptor trigger zone (CTZ) of the brain and may prevent chemotherapy-induced emesis. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39564&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39564&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C774" NCI Thesaurus) |
| Definition (NCI) | A synthetic propylpiperazine derivative of phenothiazine with antiemetic, antipsychotic, antihistaminic, and anticholinergic activities. Prochlorperazine antagonizes the dopamine D2-receptor in the chemoreceptor trigger zone (CTZ) of the brain and may prevent chemotherapy-induced emesis. (NCI04) |
| Concepts | Organic Chemical (T109)
, Pharmacologic Substance (T121)
|
| English | PCPZ, Prochlorperazine, PROCHLORPERAZINE PREPARATION, RP 6140 |
| Spanish | proclorperacina, proclorperazina |
| Credits | Derived from the NIH UMLS (Unified Medical Language System)
|
|
|---|
| Concepts | Organic Chemical (T109)
, Pharmacologic Substance (T121)
|
| English | Compazine |
| Spanish | compacina, compazina |
| Credits | Derived from the NIH UMLS (Unified Medical Language System)
|
Navigation Tree